Richard C. Yocum
2007 - Halozyme Therapeutics
In 2007, Richard C. Yocum earned a total compensation of $420.7K as Vice President — Clinical Development and Medical Affairs at Halozyme Therapeutics, a 26% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $70,900 |
|---|---|
| Option Awards | $81,030 |
| Salary | $268,500 |
| Other | $306 |
| Total | $420,736 |
Yocum received $268.5K in salary, accounting for 64% of the total pay in 2007.
Yocum also received $70.9K in non-equity incentive plan, $81K in option awards and $306 in other compensation.
Rankings
In 2007, Richard C. Yocum's compensation ranked 6,581st out of 8,700 executives tracked by ExecPay. In other words, Yocum earned more than 24.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,581 out of 8,700 | 24th |
Division Manufacturing | 2,523 out of 3,314 | 24th |
Major group Chemicals And Allied Products | 567 out of 746 | 24th |
Industry group Drugs | 401 out of 546 | 27th |
Industry Biological Products, Except Diagnostic Substances | 78 out of 118 | 34th |
Source: SEC filing on April 2, 2009.
Yocum's colleagues
We found five more compensation records of executives who worked with Richard C. Yocum at Halozyme Therapeutics in 2007.
2007
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2007
William Fallon
Halozyme Therapeutics
Vice President Manufacturing and Operations
2007
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2007
Gregory Frost
Halozyme Therapeutics
Chief Scientific Officer
2007
David Ramsay
Halozyme Therapeutics